<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The group of seronegative rheumatic <z:e sem="disease" ids="C0949691" disease_type="Disease or Syndrome" abbrv="SPDA1">spondylarthropathies</z:e> (<z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondarthritis</z:e>) includes different diseases with common features </plain></SENT>
<SENT sid="1" pm="."><plain>The common characteristics of these diseases are <z:e sem="disease" ids="C0574960" disease_type="Disease or Syndrome" abbrv="">sacroiliitis</z:e> and/or <z:e sem="disease" ids="C0038012" disease_type="Disease or Syndrome" abbrv="">spondylitis</z:e>, usually oligoarticular <z:hpo ids='HP_0001369'>arthritis</z:hpo>, distinct extraarticular manifestations of the skin, mucous membranes, eyes and internal organs, and a common genetic disposition </plain></SENT>
<SENT sid="2" pm="."><plain>To differentiate the diseases within this group, of which <z:e sem="disease" ids="C0038012" disease_type="Disease or Syndrome" abbrv="">spondylitis</z:e> ankylosans counts as the prototype, allowance must be made for radiomorphological changes of the spine, the various joints involved and the type of extraarticular symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>The therapy depends upon the type of disease, although the therapeutic principles remain the same as far as the spine is concerned; pain treatment and conservation of spine mobility are the main factors </plain></SENT>
</text></document>